SHORTList
10x Science logo
Biotech/Pharma

10x Science

The AI-native platform for next-generation protein characterization.

CORE INFO

$4.8M
Total Funding
Seed
Round
2025
Founded
2-10
Team Size
San Francisco, California, USA
Headquarters

10x Science offers an AI-native platform that automates protein characterization, helping pharmaceutical and biotech companies streamline drug development by providing rapid molecular insights.

  • The company raised a $4.8 million seed round in April 2026, led by Initialized Capital, with participation from Y Combinator and other investors.prnewswire.com
  • TechCrunch highlighted 10x Science's innovative approach to overcoming bottlenecks in AI-driven drug discovery by integrating deterministic algorithms with AI agents.techcrunch.com

WHY WE WOULD WORK AT 10X SCIENCE

Innovative AI Technology

Join a pioneering team that leverages AI-driven protein characterization to revolutionize drug development, making a real impact in the biopharmaceutical industry.

Collaborative Team Environment

Work alongside a small, expert team of researchers from Stanford University, fostering a culture of high velocity and leadership in modern AI development.

Competitive Compensation

Benefit from a competitive salary and equity options as part of a startup that has successfully raised $4.8 million in seed funding.

Mission-Driven Work

Contribute to a mission that accelerates drug development, enabling biopharmaceutical innovations to keep pace with AI-powered discoveries.

Cutting-Edge Solutions

Utilize an AI-native platform that automates complex protein characterization, transforming traditional workflows into rapid, efficient processes.

Recognized Industry Potential

Be part of a company recognized by Y Combinator, showcasing strong commercial traction with enterprise pharmaceutical clients and a promising future.

MARKET AND TRACTION

TOTAL ADDRESSABLE MARKET

  • 10x Science operates within the pharmaceutical and biotech industries, which are rapidly evolving due to advancements in AI and machine learning.

  • The increasing demand for efficient drug development processes presents a significant market opportunity for AI-driven solutions like those offered by 10x Science.

    • NOTABLE CUSTOMERS

  • 10x Science has reported strong commercial traction with enterprise pharmaceutical customers, indicating a growing interest in its AI-driven protein characterization platform.

  • The company's collaborations with these clients highlight its relevance and potential impact in the drug development sector.

    • KEY METRICS

    ✦ KEY METRIC
  • Total Funding: 10x Science has successfully raised $4.8 million in its seed funding round.

  • Founded in 2025, the company is still in its early stages, with a small team size of 2-10 employees, which reflects its startup nature and growth potential.

    • GROWTH TACTICS

  • 10x Science aims to streamline drug development workflows by offering an AI-native platform that automates protein characterization and quality assessment.

  • The company focuses on providing automated, explainable molecular insights to help drug developers make informed decisions quickly.

    • COMPETITIVE ADVANTAGE

  • The integration of deterministic chemistry algorithms with AI agents allows 10x Science to interpret complex mass spectrometry data more rapidly and accurately than traditional methods.

  • This unique approach positions 10x Science as a leader in the AI-driven protein characterization space, addressing a critical bottleneck in drug development.

    • PRODUCT AND TECH

    AI-Native Platform

    10x Science offers an AI-native platform that automates protein characterization and quality assessment, significantly reducing the time and effort required in traditional workflows.

    Deterministic Chemistry Algorithms

    The platform integrates deterministic chemistry algorithms that work alongside AI agents to interpret complex mass spectrometry data, enabling rapid and accurate protein characterization.

    Automated Molecular Insights

    The service provides automated, explainable molecular insights in minutes, allowing drug developers to make informed decisions about advancing or halting candidate development early in the process.

    B2B SaaS Model

    Operating on a B2B SaaS model, 10x Science collaborates with pharmaceutical and biotech companies to streamline their drug development workflows, enhancing efficiency and effectiveness.

    Rapid Drug Development

    By transforming a traditionally manual process into a rapid, automated one, 10x Science aims to keep biopharmaceutical development in sync with the pace of AI-powered drug discovery.

    COMPANY CULTURE

    Values

  • Innovation at the forefront of drug development

  • Commitment to quality and accuracy in protein characterization

  • Collaboration with pharmaceutical and biotech partners

  • Integrity in data interpretation and insights

  • Passion for advancing biopharmaceutical research

    • Operating Principles

  • Emphasis on high velocity in project execution

  • Data-driven decision making to guide development

  • Integration of AI with deterministic chemistry for efficiency

  • Continuous improvement of workflows and processes

  • Focus on explainable AI to enhance user trust

    • Benefits

  • Rapid automation of protein characterization processes

  • Enhanced decision-making capabilities for drug developers

  • Support for early identification of suitable drug candidates

  • Access to cutting-edge AI technology in life sciences

  • Opportunities for collaboration with industry leaders

    • Team Cadence

  • Agile work environment promoting quick iterations

  • Regular team meetings to align on project goals

  • Open communication channels for feedback and ideas

  • Emphasis on cross-functional collaboration among team members

  • Flexible work arrangements to support productivity

    • Learning & Growth

  • Opportunities for professional development in AI and life sciences

  • Encouragement of knowledge sharing among team members

  • Access to industry conferences and workshops

  • Mentorship from experienced leaders in the field

  • Focus on fostering a culture of continuous learning

    • HIRING SIGNAL

    0
    Open roles on their careers page
    Snapshot via live ATS poll
    —
    Net new roles in the last 90 days
    Available once weekly history accrues
    90-Day VelocityV2 · BACKFILL
    Trend builds weekly as historical rows accrue
    SourcesGreenhouseLeverAshbyWorkableSmartRecruitersRipplingRecruiteeFallback · Wellfound, YC Work-at-a-Startup, careers-page scrape

    KEY COMPANY ANNOUNCEMENTS

    Filter
    2 announcements · ranked by importance
    Apr 22, 2026FUNDING10x Science Raises $4.8M Seed to Build AI That Understands Proteins at the Molecular Levelprnewswire.com
    Apr 22, 2026FOUNDER PROFILE10x Science: The Founders Who Built the Fieldblog.initialized.com